Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAUNA: Selective vs Universal Antibiotics for Preterm Neonates At-risk of Early-onset Sepsis
NCT06377397Phase 3Recruiting
- Sponsor
- Indian Council of Medical Research
- Start
- Jun 2025
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Phase 3, randomised trial in Early-onset neonatal sepsis (EONS) (2 arms), sponsored by Indian Council of Medical Research. Primary endpoints: Composite of all-cause mortality and/or any episode of culture-positive sepsis and/or severe sepsis at 7 days and All-cause mortality or cumulative intravenous antibiotic exposure exceeding 48 hours at 7 days. Started Jun 2025; status: recruiting.
02
Conditions
Early-onset neonatal sepsis (EONS)
Beyond the preview
Go deeper on NCT06377397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06377397.